MedPath
HSA Approval

DIPHEN 5 EXPECTORANT

SIN08782P

DIPHEN 5 EXPECTORANT

DIPHEN 5 EXPECTORANT

July 3, 1996

ICM PHARMA PTE. LTD.

ICM PHARMA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantICM PHARMA PTE. LTD.
Licence HolderICM PHARMA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

R05FB01

cough suppressants and mucolytics

Manufacturer Information

ICM PHARMA PTE. LTD.

ICM PHARMA PTE. LTD.

Active Ingredients

AMMONIUM CHLORIDE

62.5 mg/5 ml

Ammonium chloride

DIPHENHYDRAMINE HCl

5 mg/5 ml

Diphenhydramine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DIPHEN 5 EXPECTORANT - HSA Approval | MedPath